22-41714062-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_152513.4(MEI1):āc.410A>Cā(p.Glu137Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000198 in 1,598,816 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_152513.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MEI1 | NM_152513.4 | c.410A>C | p.Glu137Ala | missense_variant | 4/31 | ENST00000401548.8 | NP_689726.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MEI1 | ENST00000401548.8 | c.410A>C | p.Glu137Ala | missense_variant | 4/31 | 1 | NM_152513.4 | ENSP00000384115 | P1 | |
MEI1 | ENST00000540833.1 | c.-371A>C | 5_prime_UTR_variant | 4/20 | 5 | ENSP00000444225 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152192Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000258 AC: 58AN: 224988Hom.: 0 AF XY: 0.000273 AC XY: 33AN XY: 120972
GnomAD4 exome AF: 0.000204 AC: 295AN: 1446624Hom.: 0 Cov.: 31 AF XY: 0.000185 AC XY: 133AN XY: 717850
GnomAD4 genome AF: 0.000145 AC: 22AN: 152192Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74364
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 29, 2024 | The c.410A>C (p.E137A) alteration is located in exon 4 (coding exon 4) of the MEI1 gene. This alteration results from a A to C substitution at nucleotide position 410, causing the glutamic acid (E) at amino acid position 137 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at